BNTX
BioNTech SE
BNTX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
BNTX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Strong | |
| Strong |
BNTX's cash flow and balance sheet are currently strong, but its revenue and profitability are under pressure.
BNTX PE Valuation
BNTX has no meaningful PE right now: it lost money over the past year.
BNTX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect BNTX's losses to grow, with revenue declining. However, they disagree widely on these estimates.
BNTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$7.48 | -$5.88 |
| Q1 2026 | -$5.65 | -$2.03 |
| Q4 2025 | -$5.20 | -$2.05 |
| Q3 2025 | -$2.63 | -$0.32 |
| Q2 2025 | -$1.60 | +$0.84 |
| Q1 2025 | -$3.62 | -854% |
| Q4 2024 | -$3.15 | -175% |
| Q3 2024 | -$2.31 | -119% |
BNTX lost $7.48 per share over the past year, and its loss has widened in each of the last four quarters.
BNTX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $117.3M | -60% |
| Q1 2026 | $133.4M | -34% |
| Q4 2025 | $998.6M | -24% |
| Q3 2025 | $1.7B | +22% |
| Q2 2025 | $289.7M | +103% |
| Q1 2025 | $203.1M | -2.6% |
| Q4 2024 | $1.3B | -20% |
| Q3 2024 | $1.4B | +39% |
BNTX's revenue has slid since its 2022 peak: $117M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -898% | -706 points |
| Q1 2026 | -560% | -268 points |
| Q4 2025 | -26% | -38 points |
| Q3 2025 | -3.1% | -3.9 points |
| Q2 2025 | -192% | +559 points |
| Q1 2025 | -292% | -22 points |
| Q4 2024 | 12% | -23 points |
| Q3 2024 | 0.8% | -7.3 points |
BNTX's operating margin was −898% last quarter, down 706 points from the same quarter a year ago, near the bottom of its range since 2019.
BNTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$49.8M | -106% |
| Q1 2026 | -$539.5M | +$1.1B |
| Q4 2025 | $264M | +$932.4M |
| Q3 2025 | $901.1M | +$1.8B |
| Q2 2025 | $777.7M | -56% |
| Q1 2025 | -$1.6B | -$1.1B |
| Q4 2024 | -$668.4M | -153% |
| Q3 2024 | -$865.1M | -218% |
BNTX's free cash flow has turned positive again: $576M over the past year, against −$2.4B the year before.
BNTX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +449K shares |
| 1 year | +4.8% | +11.7M shares |
| 3 years | +5.7% | +13.6M shares |
| 5 years | -2.1% | -5.5M shares |
| Available history | +10% | +23.9M shares |
BNTX has 253M diluted shares, up 4.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $146.7M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BNTX spent $147M buying back its own shares over the past year, after none the year before.
BNTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | -149.4x | Net Cash |
| Q4 2023 | -10.3x | Net Cash |
| Q3 2023 | -3.4x | Net Cash |
| Q2 2023 | -2.3x | Net Cash |
| Q1 2023 | -1.5x | Net Cash |
| Q4 2022 | -1.0x | Net Cash |
| Q3 2022 | -0.9x | Net Cash |
| Q2 2022 | -0.5x | Net Cash |
BNTX has more cash than debt.
BNTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.6 | Neutral |
| Stochastic | 5.7 | Oversold |
BNTX's weekly RSI is 41 (neutral) and its Stochastic is 6 (oversold).
BNTX PE vs Healthcare Sector
| Metric | BNTX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BNTX has no meaningful PE right now: it lost money over the past year.
BNTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $91.1 | 6.7% below |
| 20 week MA | $94.6 | 10% below |
| 50 week MA | $96.6 | 12% below |
| 100 week MA | $101.4 | 16% below |
| 200 week MA | $103.6 | 18% below |
BNTX is in a downtrend: it's below all five of its weekly moving averages, and 18% below its 200-week average.
BNTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.6 | $97.0 | +198% |
| 2021 | $97.0 | $255.3 | +163% |
| 2022 | $255.3 | $176.0 | -31% |
| 2023 | $176.0 | $105.5 | -40% |
| 2024 | $105.5 | $114.0 | +8% |
| 2025 | $114.0 | $94.5 | -17% |
| 2026 YTD | $94.5 | $85.0 | -10% |
BNTX's yearly returns have swung widely, from +198% in 2020 to −40% in 2023. It's down 10% so far in 2026.